Otitis media (OM) is a common childhood disease characterised by middle ear inflammation following infection. Susceptibility to recurrent acute OM (rAOM) and chronic OM with effusion (COME) is highly heritable. Two murine mutants, Junbo and Jeff, spontaneously develop severe OM with similar phenotypes to human disease. Fine-mapping of these mutants identified two genes (Evi1 and Fbxo11) that interact with the transforming growth factor b (TGFb) signalling pathway. We investigated these genes, as well as four Sma-and Mad-related (SMAD) genes of the TGFb pathway, as candidate rAOM/COME susceptibility genes in two predominantly Caucasian populations. Single-nucleotide polymorphisms (SNPs) within FBXO11 (family-based association testing Z-Score ¼ 2.61; P best ¼ 0.009) were associated with severe OM in family-based analysis of 434 families (561 affected individuals) from the Western Australian Family Study of OM. The FBXO11 association was replicated by directed analysis of Illumina 660W-Quad Beadchip data available for 253 cases and 866 controls (OR ¼ 1.55 (95% CI 1.28-1.89); P best ¼ 6.9 Â 10 À6 ) available within the Western Australian Pregnancy Cohort (Raine) Study. Combined primary and replication results show P combined ¼ 2.98 Â 10 À6 . Neither cohort showed an association with EVI1 variants. Family-based associations at SMAD2 (P ¼ 0.038) and SMAD4 (P ¼ 0.048) were not replicated. Together, these data provide strong evidence for FBXO11 as a susceptibility gene for severe OM.
Introduction
Otitis media (OM), one of the most common diseases of early childhood, is characterised by inflammation of the middle ear, often with effusion. The inflammation is triggered by infection and leads to a variety of related clinical phenotypes. Acute otitis media (AOM) is an acute, usually bacterial infection of the middle ear, characterised by fever and painful inflammation of the tympanic membrane. The majority of children have at least one episode of AOM by school age, with 40% suffering from recurrent AOM 1 (rAOM: X3 episodes in 6 months or X4 episodes in 12 months). OM with effusion, a common sequelae of rAOM, is a non-purulent middle ear effusion, which may become chronic (COME). Both rAOM and COME may lead to perforation of the tympanic membrane, conductive hearing loss, delayed speech development and poor educational outcomes. 2 Treatment for rAOM and COME may include insertion of tympanostomy tubes. In Australia, the cost of OM treatment was estimated at AUD$100-$400 million in 2008 (see ref. 3) .
Both genetic and environmental factors predisposing children to rAOM and OM with effusion have been described. The genetic risk has been quantified by heritability data from twins and triplets. Self-reported data from Norwegian twins gave a heritability estimate of 0.74 for females and 0.45 for males. 4 In the United States, analysis of twins and triplets with physiciandiagnosed OM in the first few years of life gave a heritability of 0.73 for the total time with middle ear effusion, but with no sex differences. 5 A longitudinal study reported that the heritability of symptom scores, composed of ear infection and respiratory symptoms, increased with age, from 0.49 at age 2 to 0.71 at age 4 (see ref. 6 ). These studies confirm a substantial heritable component to the broad clinical spectrum of OM. Environmental risk factors, 7 including attendance at day care, exposure to tobacco smoke and short duration of breastfeeding, also have an important role and may be important covariates of heritable risk.
To identify genes involved in OM susceptibility, mouse mutagenesis studies have investigated murine models with a conductive deafness phenotype and identified two mouse models, Junbo (Jbo) and Jeff (Jf ), with pathological signs comparable to OM in humans. Homozygous Jbo/Jbo and Jf/Jf mice are lethal in utero or early life, with a range of developmental abnormalities. However, heterozygous Jbo/ þ mice develop bilateral chronic suppurative OM 29 days after birth, which is not associated with major developmental malformations or immune deficiencies. 8 The Jbo mutation maps to a zincfinger domain at the Evi1 gene. Jf homozygotes die shortly after birth and display a number of developmental abnormalities, including cleft palate and eyes open at birth. Heterozygous Jf/ þ mice develop COME 28 days after birth, again in the absence of severe craniofacial abnormalities. 9 The Jf mutation maps to the Fbxo11 gene. Interestingly, both mutant mouse strains develop chronic OM in specific pathogen-free conditions. Allelic association analysis of single-nucleotide polymorphism (SNP) variants in the human FBXO11 gene carried out in the predominantly Caucasian Minnesota COME/ROM Family Study cohort identified nominal evidence for association at rs2134056 (P ¼ 0.02) (see ref. 10) .
Given the phenotypic similarities between Jbo þ /À and Jf þ /À mice and human OM, the human orthologues were selected as candidate genes for association analysis with rAOM and COME susceptibility. Preliminary functional 11 and pathway analyses revealed that both EVI1 and FBXO11 proteins interact in the transforming growth factor b (TGFb) signalling pathway. On the basis of this, four Sma-and Mad-related (SMAD) mediators of the TGFb pathway (SMAD2, SMAD3, SMAD4 and SMAD7) were also investigated as susceptibility determinants of OM. To establish whether these genes have a role in determining susceptibility to rAOM and COME, familybased allelic association analysis with replication in an independent case-control cohort was carried out.
Results
Allelic association analysis of FBXO11 and EVI1 polymorphisms Family-based association testing results are shown in Table 1 . Significant association under a recessive model was observed at two of five polymorphisms in FBXO11, rs12712997 (Z-score þ 2.61; P ¼ 0.009) and rs330787 (Z-score þ 1.94; P ¼ 0.053). In both cases the major allele was disease associated (A for rs12712997; C for rs330787). No other polymorphisms in FBXO11 showed significant association with disease, including FBXO11/rs2134056, which was previously shown to be associated with OM. 10 There was no significant association with any EVI1 polymorphism.
Analysis using univariate logistic regression analysis of data available from the Western Australian Pregnancy Cohort (Raine) Study ('the Raine Study') replicated the significant results observed in the family-based association testing analysis for FBXO11 polymorphisms (see Table 2 and Supplementary Linkage disequilibrium and haplotype analysis at FBXO11 Pairwise linkage disequilibrium (LD) between the two associated FBXO11 polymorphisms (rs330787 and rs12712997) in the primary cohort is high (r 2 ¼ 0.75; D 0 ¼ 0.89), indicating that these polymorphisms likely exist on the same haplotype. Forward stepwise casepseudocontrol conditional logistic regression analysis supported this, as neither polymorphism contributed significant additional main effects to a model containing the other (that is, adding rs330787 to rs12712997: P ¼ 0.858; and adding rs12712997 to rs330787: P ¼ 0.518). Haplotypic analysis using haplotype-based association tests (HBAT) identified one haplotype, carrying both major alleles, as significantly associated with OM under a recessive model (rs330787C: rs12712997A; Z-score þ 2.31; P ¼ 0.021).
LD analysis in the replication cohort showed a similar pattern of pairwise LD between rs330787 and rs12712997 in the replication cohort (r .68) but not between each group (that is, r 2 p0.14). All markers that fall in LD block 1 show significant disease associations at the major allele, whereas those in LD block 2 show significant disease associations at the minor allele (Table 2 ). FBXO11/ rs330787 and FBXO11/rs12712997, which are associated in both the primary and replication cohorts, fall in LD block 1. FBXO11/rs2134056, which was associated with COME/ROM in the Minnesota Family Study 10 but was not associated in our study, does not belong to either LD block (r 2 p0.12).
FBXO11 associated with severe otitis media MS Rye et al
To determine whether the association observed with members of LD block 2 in the replication study is indicative of an independent disease effect at FBXO11 in this population, we undertook both haplotype analysis in Haploview and a forward stepwise logistic regression analysis in STATA v10. The haplotype analysis confirmed that significantly overtransmitted haplotypes for LD block 1 markers always comprised major alleles (Table 3a) , whereas the significantly overtransmitted haplotypes for LD block 2 markers always comprised minor alleles (Table 3b) . Haplotype analysis across all eight associated SNPs also shows that the minor alleles at LD block 2 SNPs are only significantly overtransmitted when on a haplotype with the major alleles of LD block 1 SNPs (Supplementary Table 4 ), suggesting that the markers in LD block 2 do not represent an independent disease effect.
To further confirm this, stepwise logistic regression analysis was used to determine whether independent effects existed at the significantly associated markers within each LD block and between each LD block. Within LD block 1, only rs330787 and rs12620679 contributed significant independent effects when compared with other LD block 1 markers, whereas in LD block 2 only rs10182633 contributed significant independent effects when compared with other LD block 2 markers (Supplementary Table 5 ). This suggests that rs330787 and rs12620679 account for the association observed with LD block 1 markers, whereas rs10182633 accounts for the association observed with LD block 2 markers. When comparing between the two LD blocks, rs330787 (used as the most significantly associated SNP in LD block 1) adds independent main effects (P ¼ 0.001) to rs10182633, but the converse does not hold true (P ¼ 0.06), again suggesting that the markers in LD block 2 do not represent an independent disease effect. In summary, the haplotype and stepwise logistic regression analyses are most consistent with a single disease association in this replication cohort, which is attributable to an aetiological variant in strong LD with rs330787.
Allelic association analysis of TGFb signalling pathway members Analysis of TGFb signalling pathway members in the primary OM cohort (Supplementary Table 2 ) identified significant association at the major alleles of rs1792658 in SMAD2 (Z-score þ 2.08; P ¼ 0.038) and at rs10502913 in SMAD4 (Z-score þ 1.98; P ¼ 0.048). No significant associations were identified at SMAD3 or SMAD7 (P40.05). Replication in the Raine Study cohort using univariate and multivariate analysis of all SMAD2, SMAD3, SMAD4 and SMAD7 polymorphisms from the primary cohort, plus an additional 306 polymorphisms, did not reveal any significant associations robust to multiple testing correction (P uncorrected X0.03). Univariate and multivariate analyses of polymorphisms at an additional 13 TGFb signalling pathway members (Supplementary  Table 3A ) in the Raine Study data did not reveal any significant associations robust to multiple testing correction (P uncorrected X0.001).
Discussion
This study investigated whether variants at the human orthologues, FBXO11 and EVI1, for the well-characterised mouse mutants Jeff (Fbxo11) and Junbo (Evi1) are associated with OM in humans. In both our primary sample of families from the Western Australian Family Study of OM and in a replication cohort derived from the Raine Study we found significant association with variants at FBXO11 (best combined P-value ¼ 2.98 Â 10
À6
) but not at EVI1. Together, these two independent data sets provide strong evidence of a role of the FBXO11 gene in susceptibility to severe/recurrent OM in this predominantly Caucasian population, which seems to exert an effect independently of known environmental determinants.
In our study, the FBXO11 association was observed across the spectrum (rAOM/COME) of clinically severe OM. This is broadly concordant with a previously reported association between FBXO11 and recurrent OM/COME in The Minnesota COME/ROM Family Study, 10 although we did not replicate association with the same SNP (rs2134056), which falls outside the haplotype blocks containing our disease-associated SNPs. Conversely, the previous study did not observe an association with rs330787, the most significantly associated SNP observed here, despite the fact that all three cohorts comprise predominantly Caucasian children. Further work is required to determine whether different haplotypes occur in the United States of America compared with Australian children used in FBXO11 associated with severe otitis media MS Rye et al these studies, and whether this could be capitalised on to map the precise aetiological variants for disease in both geographical locations. The FBXO11 protein is a member of the F-box family, a group of SCF E3 ligases containing a protein domain with a role in ubiquitination and degradation of phosphorylated proteins. 13 There are limited data on the role of FBXO11 in humans; however, functional studies in mice have identified a role in the regulation of the TGFb signalling pathway. 11 During embryonic development, mice homozygous for the Jf mutation show increased expression and accumulated nuclear FBXO11 for (A) markers 1, 3, 4 and 8 in LD block 1 (see Figure 1 ) and (B) markers 2, 5, 6 and 7 in LD block 2 (see Figure 1) Abbreviations: LD, linkage disequilibrium; SNPs, single-nucleotide polymorphisms. Significant P-values are shown in bold, those approaching significance are shown in italics.
FBXO11 associated with severe otitis media MS Rye et al localisation of phospho-Smad2 (pSmad2) in epithelial cells of the eyelid, palate and lung. 11 Furthermore, it has been shown that FBXO11 neddylates p53 suggesting a role for FBXO11 in the stabilisation of p53, (see ref. 14) a known cofactor of pSmad2. This proposed role is supported by the observation that Jf/Jf mice show reduced levels of p53 (see ref. 11) As such, FBXO11 may have a putative role that relates to the diverse functions of the TGFb signalling pathway, including embryonic development and immunological regulation, both of which may be important determinants of OM susceptibility and are discussed briefly here.
On a C3H/HeH background, 9 Jf homozygous mutant mice have severe developmental defects, including cleft palate, which is a developmental condition known to increase the prevalence of OM in humans, 15 whereas heterozygous Jf/ þ mice demonstrate mild craniofacial abnormalities, such as a shortened snout and smaller eustachian tubes. Whilst these craniofacial abnormalities may contribute to the OM susceptibility observed in these mice, it has been shown that on a C57BL/6 background Jf/ þ mice have no apparent craniofacial defects although they do still develop OM (SD Brown, unpublished data 16 ). This suggests that craniofacial abnormalities are not the major mechanism of FBXO11 function in OM susceptibility, although subtle differences in craniofacial or Eustachian tube development cannot be completely discounted.
Instead, a role in inflammatory dysfunction may be the key mechanism underlying the increased susceptibility to OM. In support of this is the observation that Jf/ þ mice develop COME 28 days after birth under specific pathogen-free conditions. This is possibly because of an inability to control chronic inflammation in the middle ear, due to either a constitutive inflammatory process or in response to commensal bacteria, consistent with a defect in the known anti-inflammatory activity of the TGFb pathway. 17 Analysis of other key genes in the TGFb pathway, specifically SMAD2, SMAD3, SMAD4 and SMAD7, revealed only borderline genetic associations at SMAD2 and SMAD4. These were not replicated in the Raine Study cohort. We cannot rule out that the lack of replication at SMAD2 and SMAD4 maybe due to subtle differences in phenotype or exposures to environmental determinants between the primary and replication cohorts; thus, further replication in additional cohorts should be undertaken. No additional genetic associations were observed with other members of the TGFb pathway in the Raine Study cohort.
Our study was not sufficiently powered (or designed) to determine whether FBXO11 was more strongly associated with rAOM or COME. Future studies using larger sample sizes of children with a specific rAOM or COME phenotype are needed to firmly establish the relationship between FBXO11 variants and different OM phenotypes. In our study the tag-SNPs selected to cover the FBXO11 gene in the Western Australian Family Study of OM, plus those analysed for the Raine Study, were all intronic and unlikely to represent functional variants, although enhancers are known to fall within intronic regions. Ongoing fine-mapping aims to identify the aetiological variants at FBXO11 associated with OM. For the moment, associations with polymorphisms at FBXO11 in three separate cohorts confirm a role for this gene in susceptibility to childhood OM. These results provide some progress to improved understanding of the pathogenesis of this disease in humans.
Study population and methods
Sample collection and phenotype definition Recruitment to the Western Australian Family Study of OM commenced in 2007. The study was approved by the human research ethics committee at Princess Margaret Hospital for Children (#1428/EP). Probands with a history of tympanostomy tube insertion for rAOM or COME were identified from medical records of collaborating ear, nose and throat (ENT) specialists. Parents and affected siblings (defined as X3 physician-diagnosed episodes of AOM or tympanostomy tube insertion for rAOM/COME) were also recruited to the family-based study. No exclusion was made on the basis of ethnicity.
Following informed consent, study participants provided either a non-invasive saliva sample or, for a subset of probands, a blood sample at the time of tympanostomy tube insertion for DNA extraction, and parents completed a study-specific questionnaire. Information on exposure to known environmental risk factors such as attendance at day care, duration of breastfeeding and exposure to tobacco smoke was also obtained, together with data on episodes of OM and their management. Children with predisposing medical conditions (that is, immune deficiencies, craniofacial abnormalities and specific genetic syndromes) were excluded from the study. Family members with no history of rAOM were classified as unaffected, whereas all others were classified as unknown. In total, 561 affected individuals from 434 families, containing up to four affected siblings, were available for inclusion in the study. In all, 92% of families self-identified themselves as Caucasian.
For replication, we used the Western Australian Pregnancy Cohort (Raine) Study ('the Raine Study'), a longitudinal cohort of children whose mothers were recruited during early pregnancy and who are now in the 20th year of follow-up. 18 Genome-wide Illumina 660W-Quad Beadchip data are available on 1198 Caucasian Raine Study participants. Clinical data collected during the first 3 years of life indicating retracted or scarred tympanic membranes, middle ear effusion or tympanostomy tube insertions or parental reporting of X3 episodes of AOM by age 3 years were used to identify 253 children with a history consistent with OM (cases). As for the family-based study, these children represent the broad spectrum (rAOM/COME) of severe OM. Of the remaining children, 866 had no OM history and were used as controls. Data on relevant epidemiological risk factors, including tobacco smoke exposure, attendance at day care and duration of breastfeeding, are available for Raine Study participants.
DNA extraction
Genomic DNA was extracted from 2 ml of saliva for the majority of participants using the Oragene technology (DNA Genotek, Ontario, Canada) as per the manufacturer's instructions. For a subset of children, blood samples were collected at the time of tympanostomy tube insertion and DNA was extracted from neutrophil pellets using a salting-out method. 19 Extracted DNA was resuspended in TE buffer, quantified using spectrophotometry and stored at À20 1C.
Selection of genes and SNPs-Western Australian family study of otitis media The FBXO11 and EVI1 genes were initially selected as candidates for human OM on the basis of data from murine models. Functional data from mouse models, 8, 9 combined with Ingenuity pathway analysis (Ingenuity Systems, http://www.ingenuity.com), indicated that both gene products interact with the TGFb pathway and thus other key genes in this pathway-SMAD2, SMAD3, SMAD4 and SMAD7-were also investigated. For genotyping in the family cohort, a minimum of two haplotype tagging (tag) SNPs were selected for each gene using data from the Caucasian population in the International HapMap Project. 20 Where possible, tagSNPs with a minor allele frequency (MAF) X0.2 were selected. The previously OM-associated FBXO11 rs2134056 polymorphism 10 was also included in the family-based analysis (Supplementary Table 1 ). All SNPs were intronic, apart from EVI1/rs10936575, which lies in the 3 0 -untranslated region.
Selection of genes and SNPs-the Raine study For replication, we used directed analysis of cleaned, 21 imputed 22 genome-wide Illumina 660W-Quad Beadchip data available on 1198 Caucasian Raine Study participants. This included replication analysis of all SNPs genotyped in the primary OM cohort, plus analysis of additional SNP markers within these genes/regions available in the genome-wide data set. Access to genome-wide data also afforded the opportunity to expand the analysis in the Raine Study cohort to include additional members of the TGFb pathway. In total, data for 1504 polymorphisms across 19 TGFb pathway members were available for analysis (see Supplementary  Table 3A) .
SNP genotyping and quality control TaqMan (Life Technologies, Carlsbad, CA, USA) allelic discrimination was carried out according to the manufacturer's instructions. Allele calling was carried out by two independent researchers using an Applied Biosystems 7900HT Sequence Detection System (Life Technologies, Carlsbad, CA, USA). Mendelian inconsistencies were identified in family data using PedCheck software 23 and removed before statistical analysis. Hardy-Weinberg equilibrium analysis in the primary and replication data was carried out in STATA v10 (see ref. 24 ) using unaffected, unrelated individuals. No SNPs were found to significantly deviate from Hardy-Weinberg equilibrium in either cohort.
Analysis
Transmission disequilibrium test power approximations determined that 434 families have 96% power to detect allelic association, with an effect size or OR of 2 at P ¼ 0.001 for SNPs with a MAF X0.2. This underestimates the true power, as multiple affected siblings were available in some families (total 561 affected individuals). Comparison of 253 cases vs 866 controls available within the Raine Study has 98% power to detect OR ¼ 2 at P ¼ 1 Â 10 À4 for SNPs with a MAF X0.2. Family-based allelic association tests, based on transmission disequilibrium test under a generalised programme that carries out an analysis of additive, dominant and recessive inheritance models, were conducted within the program FBAT under the null hypothesis of 'no linkage and no association'. 25 Family-based association testing analysis is robust to the presence of multiple affected individuals in families. Family-based haplotype analysis was carried out in HBAT 25 for genes with multiple significantly associated SNPs. Unconditional logistic regression was used to analyse replication data from the Raine Study. Forward stepwise logistic [regression analysis, using either a case-pseudocontrol (family cohort) or case-control (Raine Study) data set, was used to determine the presence of independent effects between multiple associated polymorphisms within a gene/region. 26 LD and case-control haplotype association analyses were performed in Haploview 3.32 (see ref. 27) 
